› CanChew® Gum is the first CBD hemp oil chewing gum, created using AXIM® Biotechnologies patent for chewing gum as a delivery method for cannabinoids.
LATEST CANCHEW® BIOTECHNOLOGIES NEWS
Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.
CanChew® is the world’s first patented controlled-release cannabinoid chewing gum containing 50 mg of hemp oil and 10 mg of CBD.
CanChew Plus™ is a unique industrial hemp based chewing gum that is distinctly different and superior to any other brands of gum on the market. Features listed on the CanChew website include:
AXIM® Biotechnologies, Inc. (OTC:AXIM) focuses on the research, development and production of cannabinoid-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew Plus™ a CBD-based controlled release chewing gum. A clinical trial with a CanChew Plus™ containing 50 mg of CBD will enter a clinical trial in patients with IBS (irritable bowel syndrome), and MedChew Rx, a combination CBD/THC gum that will be undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. We prioritize the well-being of our customers while embracing a solid fiscal strategy. For more information, please visit www.AXIMBiotech.com.